Novel radioligands to improve radiotherapy of NETs
Kuo-Shyan Lin, PhD
Finished Projects
Novel Therapeutic Vulnerabilities in Cervical Neuroendocrine Carcinoma
Haider S. Mahdi, MD
Octreotide-targeted treatment of pancreatic NETs
Renata Pasqualini, PhD
Oncolytic viral therapy for NETs
Charles Rudin, MD, PhD
Origin and differentiation of a new class of serotonin-expressing enteroendocrine cells
Andrew Leiter, MD, PhD
Overcoming Resistance to mTOR Inhibition in pancreatic NETs
Eric Nakakura, MD, PhD
Personalized Immunotherapy for Atypical Pulmonary Carcinoids
Kevin McHugh, PhD
Phase 1 study of SurVaxM ™ in survivin-positive NETs
Renuka Iyer, MD
Preclinical Toxicity and Therapy Study of 225Ac-crown-TATE
Paul Schaffer, PhD
Profiling of secreted immune mediators in NETs
Matthew H. Kulke, MD